207713
1,3-Di-o-tolylguanidine
99%
Synonyme(s) :
DTG
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule linéaire :
(CH3C6H4NH)2C(=NH)
Numéro CAS:
Poids moléculaire :
239.32
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
202-577-6
MDL number:
Assay:
99%
Form:
solid
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderQuality Level
assay
99%
form
solid
mp
176-178 °C (lit.)
solubility
water: soluble 70 mg/mL at 20 °C
functional group
amine
SMILES string
Cc1ccccc1NC(=N)Nc2ccccc2C
InChI
1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18)
InChI key
OPNUROKCUBTKLF-UHFFFAOYSA-N
Gene Information
human ... EBP(10682)
General description
1,3-Di-o-tolylguanidine is a selective σ-receptor agonist. 1,3-Di-o-tolylguanidine is σ site ligand and its interaction with dopamine drugs were studied in Wistar rats and Albino Swiss mice.
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Melissa Wares et al.
Antimicrobial agents and chemotherapy, 59(4), 1942-1949 (2015-01-15)
Drug resistance represents a key aspect of human immunodeficiency virus (HIV) treatment failure. It is important to develop nonhuman primate models for studying issues of drug resistance and the persistence and transmission of drug-resistant viruses. However, relatively little work has
Zur Mira Azizah Nor Haiza Lah et al.
Journal of pharmaceutical and biomedical analysis, 174, 608-617 (2019-07-03)
A facile electrochemical sandwich immunosensor for the detection of a breast cancer biomarker, the human epidermal growth factor receptor 2 (HER2), was designed, using lead sulfide quantum dots-conjugated secondary HER2 antibody (Ab2-PbS QDs) as a label. Using Ab2-PbS QDs in
Mona Ebadi et al.
Scientific reports, 10(1), 21521-21521 (2020-12-11)
The use of nanocarriers composed of polyethylene glycol- and polyvinyl alcohol-coated vesicles encapsulating active molecules in place of conventional chemotherapy drugs can reduce many of the chemotherapy-associated challenges because of the increased drug concentration at the diseased area in the